You have 9 free searches left this month | for more free features.

Condition

Healthy (1)

Idiopathic Pulmonary Fibrosis (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Boehringer Ingelheim (2)

Collaborator

Intervention

ofev® (2)

nintedanib formulation 1 (1)

nintedanib formulation 2 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (1)

Observational (1)

ofev®

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Healthy Trial in Nottingham (Ofev®, Nintedanib formulation 1, Nintedanib formulation 2)

Recruiting

Healthy

Ofev®
+2 more

Nottingham, United Kingdom

Quotient Sciences

Aug 9, 2022

Under Routine Clinical Practice in Taiwan to Observe Long-term

Active, not recruiting

Idiopathic Pulmonary Fibrosis

OFEV®

Changhua, Taiwan
+26 more

Jan 9, 2023